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A B S T R A C T
The itinerary followed by Pseudomonas putida from being a soil-dweller and plant colonizer bacterium to become
a ﬂexible and engineer-able platform for metabolic engineering stems from its natural lifestyle, which is adapted
to harsh environmental conditions and all sorts of physicochemical stresses. Over the years, these properties
have been capitalized biotechnologically owing to the expanding wealth of genetic tools designed for deep-
editing the P. putida genome. A suite of dedicated vectors inspired in the core tenets of synthetic biology have
enabled to suppress many of the naturally-occurring undesirable traits native to this species while enhancing its
many appealing properties, and also to import catalytic activities and attributes from other biological systems.
Much of the biotechnological interest on P. putida stems from the distinct architecture of its central carbon
metabolism. The native biochemistry is naturally geared to generate reductive currency [i.e., NAD(P)H] that
makes this bacterium a phenomenal host for redox-intensive reactions. In some cases, genetic editing of the
indigenous biochemical network of P. putida (cis-metabolism) has suﬃced to obtain target compounds of in-
dustrial interest. Yet, the main value and promise of this species (in particular, strain KT2440) resides not only in
its capacity to host heterologous pathways from other microorganisms, but also altogether artiﬁcial routes (trans-
metabolism) for making complex, new-to-Nature molecules. A number of examples are presented for sub-
stantiating the worth of P. putida as one of the favorite workhorses for sustainable manufacturing of ﬁne and bulk
chemicals in the current times of the 4th Industrial Revolution. The potential of P. putida to extend its rich native
biochemistry beyond existing boundaries is discussed and research bottlenecks to this end are also identiﬁed.
These aspects include not just the innovative genetic design of new strains but also the incorporation of novel
chemical elements into the extant biochemistry, as well as genomic stability and scaling-up issues.
1. Introduction
Over the last few decades, metabolic engineering approaches, ran-
ging from very simple manipulations to sophisticated designs, have
greatly expanded the number of industrially-relevant compounds that
can be accessed via whole-cell biocatalysis (Nielsen and Keasling, 2016;
Park et al., 2018; Woolston et al., 2013). However, the most successful
histories of metabolic engineering of microorganisms have been often
conﬁned to an assortment of genetic and genomic manipulations that
lead to over-production of natively-synthesized metabolites in a
handful model microbial cell factories (Smanski et al., 2016), such as
Escherichia coli and Saccharomyces cerevisiae. Along the line, only a very
limited number of structurally simple metabolites (e.g., the diols 1,4-
butanediol and 1,3-propanediol) and a few natural active compounds
(e.g., artemisinin) have found their way towards industrial-scale pro-
duction (Chubukov et al., 2016; King et al., 2016). Actual commercia-
lization and bioprocesses account today for merely ca. 3.5% of the total
production volume of commodity and specialty chemicals (Campbell
et al., 2017). A major reason underlying this state of aﬀairs has been the
emphasis of contemporary metabolic engineering (and, in particular,
approaches aimed at engineering the core metabolism) of individual
components in the microbial cell, which resulted into a collection of
elegant demonstrations rather than generalizations. In contrast, sys-
tematic practices through the adoption of reliable, generalizable tools
in standardized microbial chasses aimed at developing biosustainable
production processes have been rather scarce. During the three decades
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that followed the establishment of metabolic engineering as a discipline
on its own merit (including the period that is often referred to as the
post-genomic era), a staggering volume of omics data has been accu-
mulated and more precise analytic techniques for studying cellular
metabolism have been established. Empowered by these rapid devel-
opments, the focus of metabolic engineers has gradually shifted away
from perturbing individual pathways and single metabolic nodes to the
manipulation of the entire cell itself, giving rise to the concept of sys-
tems metabolic engineering (Lee and Kim, 2015; Nielsen, 2017). At the
same time, the cost of oligonucleotides and de novo DNA synthesis has
declined exponentially, and the emergence of a number of tools, af-
forded by contemporary synthetic biology, has made possible to access
the metabolism of non-traditional microbial platforms. In this sense,
soil bacteria are a group of microorganisms that have attracted atten-
tion as microbial platforms since they are often exposed to extreme
environmental conditions, which correlates with a remarkable meta-
bolic and physiological robustness. Among them, the intrinsically high
metabolic diversity characteristic of Pseudomonas species, has emerged
in recent years a solid basis for designing and creating novel pathways
for bioproduction.
In this review, we present the most relevant advances in the ﬁeld of
metabolic engineering using the non-pathogenic soil bacterium
Pseudomonas putida as the functional chassis—highlighting a number of
synthetic biology approaches that made these manipulations possible.
The discussion is focused on what we perceive as the frontiers in the
ﬁeld of engineering P. putida and other environmental bacteria beyond
the canonical manipulations of the extant biochemistry towards com-
plex designs aimed at re-writing metabolism and the very microbial
lifestyle. As indicated in Fig. 1, we argue that the purposeful combi-
nation of (i) enabling technologies, such as novel synthetic biology
tools, (ii) alternative feedstocks that cannot be processed by other mi-
crobial platforms (including man-made waste streams), and (iii) the
wealth (if fairly disorganized) of omics data will strengthen the value of
P. putida as the platform of choice for the synthesis of new-to-Nature
products compatible with biosustainable industrial production. The
establishment of an authentic systems metabolic engineering of P. pu-
tida is needed to fulﬁll this purpose, and speciﬁc examples are en-
tertained as a step into this direction. The leitmotiv of these examples is
that the rational exploitation of the native metabolic architecture is
expected to uncover unique biochemistries (which we collectively refer
to as «trans-metabolisms») that enable the expansion of the biochemical
network of P. putida towards unusual elements and chemical structures,
thereby generating highly valuable compounds that could not be ac-
cessed otherwise.
2. Pseudomonas putida, primus inter pares among soil bacteria
A quick search in the relevant literature reveals that several mi-
crobial hosts have been considered and used for applications in meta-
bolic engineering (Beites and Mendes, 2015; Liu and Deutschbauer,
2018). However, to date, no single, naturally-isolated bacterial strain
seems to possess all the characteristics that would be desirable in an
optimal host. Although the emerging picture indicates that the selection
of an adequate bacterial platform will largely depend on the application
intended, the adoption of a ﬂexible and robust bacterium as the basis
for developing a functional chassis, amenable to genetic and metabolic
manipulations and endowed with high catalytic performance across a
variety of operating conditions is deﬁnitely desirable. As hinted in the
Introduction, soil bacteria in general, and P. putida in particular, could
satisfy many of these requirements because of the physicochemical
conditions they face naturally in the niches in which they thrive. These
conditions include a somewhat continuous exposure to environmental
contaminants, often together with all sorts of physicochemical stresses
and competing as well as predatory microbial species. Many environ-
mental bacterial species are widely recognized by their versatile, ﬂex-
ible metabolic lifestyles, which allow them to adapt to rapidly changing
conditions (e.g., contact with oxidative stressors, temperature chal-
lenges, and sudden osmotic perturbations). As indicated in the section
below, P. putida serves as a prime example of these qualities.
2.1. The roadmap from soil to the laboratory
The name «Pseudomonas» was coined in 1894 by Migula, who de-
scribed the genus as a group of cells with polar organs of motility and,
in some special cases, the formation of spore-like structures (Migula,
1894). This short, unclear description of the genus prevailed until the
publication of the doctoral thesis of den Dooren de Jong in the late 20s
(den Dooren de Jong, 1926). This publication revealed one of the fea-
tures that would deﬁne (and classify) the entire genus more accurately:
a remarkable capacity to degrade a large variety of organic compounds
as part of the process of carbon mineralization. The den Dooren de
Jong's thesis was, however, not widely used by contemporary scientists
(perhaps because it was written in Dutch), but held out an inspirational
vision for Stanier, Palleroni, and Doudoroﬀ, who went on creating the
ﬁrst accurate description of the Pseudomonas genus some forty years
later (Stanier et al., 1966). A set of diﬀerential tables was proposed for
the classiﬁcation of the most relevant Pseudomonas species known by
then (including P. putida), based on nutritional characteristics and
morphological features. Upon obtaining the sequence of the 16S rRNA
gene of several Pseudomonas species in 1973, the bacterial genus was
redeﬁned by Palleroni et al. (1973) to encompass the previously de-
scribed RNA-I group within the subclass of Gram-negative, aerobic γ-
Proteobacteria (Palleroni, 2003, 2010). Fig. 2 identiﬁes these mile-
stones in a timeline depicting historical developments in the ﬁeld of
Pseudomonas biology.
P. putida is a ubiquitous rhizosphere saprophytic specimen and soil
colonizer that belongs to the wide group of ﬂuorescent Pseudomonas
species. In particular, P. putida KT2440 strain is the best-characterized
saprophytic member of the group, as it has become with time a model
laboratory species which also retains its ability to survive and thrive in
natural soil environments (Regenhardt et al., 2002; Timmis, 2002;
Wackett, 2003). This P. putida strain is a derivative of P. putida mt-2,
which was isolated from a soil sample in Japan in 1960 as a degrader of
3-methylbenzoic acid (actually, «mt-2» stands for «meta-toluate de-
grader, isolate 2») (Nakazawa, 2002). This remarkable metabolic
Fig. 1. P. putida as a functional chassis for developing novel biochemistries
leading to new-to-Nature bioproducts. The adoption of speciﬁc synthetic
biology tools (enabling technologies), along with the knowledge brought about
by omics data, will help re-purposing the rich and ﬂexible central carbon me-
tabolism of P. putida to nest trans-metabolisms (with reactions and con-
nectivities alien to the extant biochemistry) leading to the synthesis of com-
pletely new chemical structures from alternative substrates. Note that the whole
process has a cyclic nature (echoing the design-build-test cycle of synthetic
biology), which beneﬁts from further manipulations to boost bioproduction.
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property was later traced to the presence of the catabolic TOL plasmid
pWW0, which encodes dedicated metabolic activities that enable P.
putida mt-2 to grow on various aromatic substrates as sole carbon and
energy sources, e.g., toluene, m-xylene, and p-xylene (Wong and Dunn,
1974; Worsey and Williams, 1975). Thus, the metabolic potential of P.
putida and some closely related Pseudomonas species was recognized
early on for applications in biodegradation of aromatic compounds.
Once the catabolic plasmid pWW0 was eliminated from strain mt-2, the
plasmid-less variant was designated as strain KT2440 (Bagdasarian
et al., 1981) and it soon became the subject of a series of genetic studies
in the laboratory, which resulted in the assignment of the generally re-
cognized as safe (i.e., GRAS) status as a microbial host for recombinant
DNA constructs (Federal Register, 1982; Nikel, 2012; Poblete-Castro
et al., 2017; Timmis, 2002). This strain also exhibits remarkable re-
sistance to oxidative stress (Kim and Park, 2014; Lemire et al., 2017;
Nikel et al., 2013; Nikel and de Lorenzo, 2014), a remarkable feature
closely associated with its capacity to degrade compounds that, on
themselves, are sources of stress.
The in silico analysis of the 6,181,873-bp long genome sequence of
P. putida KT2440, which became available ﬁrst in 2002 (Nelson et al.,
2002) and was later revisited in 2016 (Belda et al., 2016), conﬁrmed
the lack of any conspicuous virulence factor in the 5592 coding se-
quences present in the genome. The core and pangenome of P. putida
has been likewise identiﬁed (Udaondo et al., 2016). The updated
genome annotation of strain KT2440 generated a list of novel bio-
chemical functions (e.g., the assimilation of alternative carbon sources)
that were not previously identiﬁed in P. putida and resulted in a total of
1256 degradation reactions—including newly-identiﬁed catabolic
pathways for 32 carbon sources, 28 nitrogen sources, 29 phosphorus
sources, and 3 carbon and nitrogen sources. As indicated in the next
section, the extremely rich secondary metabolism of P. putida KT2440 is
wired to a robust core biochemistry characterized by a very distinct
architecture.
2.2. The unique core metabolic architecture of P. putida: Reshaping the
connectivity of sugar assimilation
In addition to its ability to use a wide variety of carbon and nitrogen
sources indicated above, rapid growth and low nutrient demand are
some of the added advantages of adopting P. putida as a chassis
(Loeschcke and Thies, 2015; Nikel et al., 2014a, 2014b; Poblete-Castro
et al., 2017). Most of these properties arise from (or are intimately
connected to) a robust central carbon metabolism (Nikel et al., 2016).
How is central carbon metabolism fueled by sugars in P. putida? Many
Pseudomonads are known to have peripheral pathways for oxidation of
sugars (e.g., to gluconate and 2-ketogluconate) in addition to the
canonical, phosphorylation-dependent routes for assimilation of
hexoses (del Castillo et al., 2007; Lessie and Phibbs, 1984; Sánchez-
Pascuala et al., 2017). Interestingly, only one phosphoenolpyruvate-
dependent sugar transport system is present in P. putida, and it is
connected to fructose uptake and phosphorylation (Pﬂüger-Grau and de
Lorenzo, 2014)—an architecture that has been recently shown to con-
form a complex regulatory device, which senses the availability of
fructose via the regulatory Cra protein and the intracellular redox status
(Chavarría et al., 2016).
Glucose is incorporated either via oxidation of the sugar to gluco-
nate or 2-ketogluconate (either oxidized product follows a dedicated
catabolic pathway for further processing) or the direct phosphorylation
by glucokinase. Irrespective of the ﬁrst steps in sugar processing (either
oxidation or phosphorylation, although the former seems to be pre-
ferred over the later in strain KT2440), these pathways converge at the
key intermediate 6-phosphogluconate—a metabolite that serves as
precursor of the Entner-Doudoroﬀ pathway and the interphase between
the oxidative and non-oxidative branches of the pentose phosphate
route. As recently reviewed by Udaondo et al. (2018), the regulation of
all these catabolic pathways for carbohydrate processing is orchestrated
by a versatile set of transcriptional regulators in Pseudomonas species.
Additionally, the combined activity of enzymes from the Entner-Dou-
doroﬀ pathway, the pentose phosphate pathway, and the incomplete
Embden-Meyerhof-Parnas route form a cyclic metabolic architecture in
P. putida KT2440 known as EDEMP cycle (Fig. 3A). When growing on
hexose sugars, the operativity of this metabolic architecture endows P.
putida with high NADPH regeneration rates via partial recycling of
triose-phosphates (Nikel et al., 2015a)—a metabolic property that is in
turn regulated by the presence and extent of oxidative stress conditions.
Furthermore, the EDEMP cycle enables diﬀerent ATP and NADPH for-
mation rates depending on the amount of triose-phosphates recycled, a
circumstance that reﬂects the speciﬁc stoichiometry of the Entner-
Doudoroﬀ pathway and the Embden-Meyerhof-Parnas pathway. The
former yields half the ATP per molecule of glucose than the later, but
produces, at the same time, one NADH and one NADPH equivalent. In
particular, and assuming that the core metabolic pathways of P. putida
KT2440 (i) use a NAD+–dependent glyceraldehyde-3-phosphate dehy-
drogenase (an activity represented by no less than ﬁve isozymes, i.e.,
GapA, GapB, Epd, PP_0665, and PP_3443) and a NADP+–dependent
glucose-6-phosphate dehydrogenase (represented by the three isozymes
Zwf, ZwfA, and ZwfB) under homeostatic physiological conditions, (ii)
yield pyruvate as the main triose end product (that is further processed
to acetyl-coenzyme A), and (iii) the ﬂuxes through the peripheral oxi-
dative loop leading to 2-ketogluconate formation are very low, the net
ﬂux of NADPH formation stemming from the activities in the EDEMP
cycle (vNADPH) increases linearly with the overall recycling ﬂux from
Fig. 2. Schematic timeline of the main ﬁndings on the isolation and characterization of P. putida. This non-extensive representation of the milestones in the ﬁeld
includes the dates of publication of key articles. Further information on historical developments can be found in the text and references therein.
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glyceraldehyde-3-phosphate upwards (vR), as indicated in Fig. 3A.
The distinct metabolic architecture in strain KT2440 when the cells
grow on sugars has two remarkable sides that oﬀer an interesting
starting point for synthetic metabolic designs. Firstly, the connectivity
that underlies the cyclic assembly of glycolytic activities in strain
KT2440. Among other peculiarities, this architecture is characterized
by the functional redundancy of at least four key activities: glucose-6-
phosphate dehydrogenase (Zwf, three isozymes), glucose-6-phosphate
isomerase (Pgi, two variants), and fructose-1,6-bisphosphate aldolase
(Fda, four potential isozymes catalyzing this gluconeogenic reaction).
Second, the existence of the EDEMP cycle (Fig. 3A) enables new stra-
tegies for engineering entirely novel biochemistries (Aslan et al., 2017).
The ability of P. putida to sustain high NADPH formation rates is a re-
quisite for implantation of what we could call redox-expensive metabolic
pathways (Akkaya et al., 2018). In this sense, diﬀerent engineering
strategies can take advantage of the inherent layout of the EDEMP
cycle. One attractive possibility for metabolic re-wiring could involve
implantation of a metabolic circuit for coupling the activity of ortho-
gonal NADPH-dependent reaction(s), leading to the target product,
with two output signals, i.e., (i) increased ﬂux through Fbp (and thus, a
higher vR ﬂux that will further boost NADPH recycling), and (ii) de-
creased ﬂuxes downwards glyceraldehyde-3-phosphate (e.g., by
blocking the Gap activities around this metabolic node), which would
prevent further catabolism into acetyl-coenzyme A (Fig. 3B). This
synthetic metabolic design would oﬀer the twofold beneﬁt of enhancing
the catalytic output of a redox-demanding bioreaction leading to the
desired product via whole-cell biocatalysis while decoupling bacterial
growth from the synthesis of the target molecule.
Besides playing with the ﬂuxes through the native reactions within
the core metabolic architecture, the gluconeogenic branch of the
EDEMP cycle could be also harnessed as a source of fructose-6-
phosphate for directly shunting the natural C6→ C2 conversion via the
phosphoketolase-catalyzed Biﬁdobacterium shunt or fructose-6-phos-
phate pathway (Fig. 3C). The reaction executed by phosphoketolase
(e.g., Xfp from B. biﬁdum or B. animalis) merges ketol cleavage, dehy-
dration, and phosphorolysis to split fructose-6-phosphate into ery-
throse-4-phosphate (which can be then transformed via the non-oxi-
dative branch of the pentose phosphate pathway) and acetyl-phosphate
(Henard et al., 2015). Importantly, Xfp also catalyzes the formation of
glyceraldehyde-3-phosphate and acetyl-phosphate from xylulose-5-
phosphate. If the split of fructose-6-phosphate between the reactions
catalyzed by Xfp and Pgi is balanced, the cycle could in principle
continue providing NADPH, which has been a limitation on the use of
the Biﬁdobacterium shunt in metabolic engineering. The C2-unit acetyl-
phosphate can be easily converted into acetyl-coenzyme A (bypassing
decarboxylation via pyruvate dehydrogenase and thus increasing ﬁnal
products yields)—and from there into a plethora of acetyl-coenzyme A-
derived, added-value products.
The two scenarios entertained above represent rather simple ma-
nipulations aimed at harnessing the potential of the native biochemistry
of P. putida via the introduction of a limited number of modiﬁcations.
Nevertheless, it is possible to further rewire what we could call «cis-
metabolism», i.e., the enzymatic parts and devices present in the extant
metabolic architecture of this bacterium. Predictably, by just re-
connecting existing endogenous reactions one could expand the port-
folio of products derived from central carbon metabolism. The practical
realization of these synthetic metabolic designs is heavily dependent on
the access to dedicated synthetic biology tools for genome and genetic
engineering—the scope of which is surveyed in the next section.
Fig. 3. The EDEMP cycle of P. putida KT2440
and two possible uses of this speciﬁc metabolic
architecture for metabolic engineering pur-
poses. (A) Glucose catabolism occurs mainly
through the activity of the Entner-Doudoroﬀ
(ED) pathway and part of the trioses-phosphate
thereby generated are recycled back to
hexoses-phosphate by means of the cycle, that
also encompasses activities from the Embden-
Meyerhof-Parnas (EMP) and pentose phos-
phate (PP) pathways. A set of peripheral oxi-
dative reactions, which convert glucose to
gluconate and 2-ketogluconate before any
phosphorylation of the intermediates occurs, is
not shown in the diagram for the sake of sim-
plicity. Each metabolic block is indicated with
a diﬀerent color along with the relevant en-
zymes catalyzing each step, and the EDEMP
cycle is shaded in blue in this illustration. The
overall stoichiometry of the ED and the EMP
routes from glucose is indicated, along with the
rate of NADPH regeneration (vNADPH) as a
function of the overall recycling ﬂux of trioses-
phosphate (vR, which depends on the com-
bined activities of Fda, Fbp, and Pgi), assuming
that there is no formation of 2-ketogluconate
through the peripheral oxidation loop. Further
processing of the C3 intermediates is indicated
with a gray arrow. The abbreviations used in
the ﬁgure are as follows: G6P, glucose-6-
phosphate; 6PG, 6-phosphogluconate; KDPG, 2-keto-3-deoxy-6-phosphogluconate; GA3P, glyceraldehyde-3-phosphate; FBP, fructose-1,6-bisphosphate; DHAP, di-
hydroxyacetone phosphate; F6P, fructose-6-P; and Pi, inorganic orthophosphate. (B) Synthetic metabolic circuit for a generic NADPH-dependent reaction that would
transform a substrate S into a product P in a positive feedback loop wired to the EDEMP cycle. The formation of P is gauged by two separate sensors connected to
individual actuators (e.g., an activator A and a repressor R) that will, in turn, boost trioses-phosphate recycling and restrict downwards catabolism of C3 units,
respectively. (C) Implantation of the Biﬁdobacterium shunt onto the upper metabolic architecture of P. putida would allow for the direct C6 to C2 conversion via
phosphoketolase (Xfp). Note that the spectrum of products P that could be potentially obtained by using this strategy encompasses virtually any metabolite derived
from acetyl-coenzyme A as the precursor. Acetyl-P, acetyl-phosphate; E4P, erythrose-4-phosphate.
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2.3. Enabling technologies for metabolic engineering of P. putida: Tools for
genome engineering and regulated gene expression
As indicated above, the entire ﬁeld of metabolic engineering is ex-
periencing a transition from being a mostly trial-and-error exercise to
become an authentic branch of rational engineering thanks to the tools
and approaches brought about by contemporary synthetic biology. A
clear indication of this transformation is our capacity to manage long
DNA molecules, which has evolved from the handling of a few genes at
a time up to synthesizing long sequences de novo and complete pro-
karyotic genomes—and soon eukaryotic chromosomes and entire gen-
omes as well. A further example of our capability of handling genetic
information includes the use of 3'→2'-phosphonomethyl-threosyl nu-
cleic acid as a xeno-genetic material for in vivo applications (Liu et al.,
2018). In all, this dynamic situation opens up possibilities for adoption
of truly engineering-based approaches for manipulating metabolic
pathways of non-traditional microbial platforms. The development and
availability of such enabling technologies is essential for the design and
implantation of veritable synthetic designs in cell factories.
Dedicated tools for gene expression have been developed for P.
putida over the years and, not surprisingly, this bacterial species has
also served as a treasure trove of functional parts (e.g., speciﬁc tran-
scriptional regulators and their cognate promoters) that have been
harnessed for the construction of novel expression systems. Table 1
presents a recompilation of these gene expression systems and plat-
forms, highlighting those cases in which novel expression platforms
have been used for metabolic engineering purposes. Building on the
wealth of catabolic pathways in P. putida, many transcriptional reg-
ulators that respond to complex molecules (e.g., the regulatory proteins
that rule aromatic degradation pathways) have been used to design
expression systems that could be considered orthogonal when im-
planted in any surrogate host. In some other cases, expression systems
developed for E. coli (Dvořák et al., 2015) have been implanted in P.
putida. For example, strain KT2440 lacks the catabolic pathway needed
for lactose processing and breakdown, therefore the LacI regulator
along with Plac and associated promoters are known to exhibit an or-
thogonal (if scarcely titrable) response in P. putida. The erratic behavior
of the LacI/Plac system (and, in reality, that of virtually any other ex-
pression platform) when placed in a heterologous host does not come as
a surprise: the internal environment of growing cells is highly variable
and dynamic (Goñi-Moreno et al., 2017), making it diﬃcult to knock-in
and manipulate reliable genetic parts. Additionally, most genetic sys-
tems have been thoroughly characterized only in laboratory E. coli
strains, making extrapolations on their quantitative behavior in alter-
native hosts almost impossible. An elegant alternative to tackle this
issue has been recently proposed by Segall-Shapiro et al. (2018), ap-
plying control-theoretic ideas to design promoters that would maintain
constant levels of expression at any copy number in E. coli. This ap-
proach may signiﬁcantly improve expression systems in P. putida,
especially considering that the plasmid copy number of well-established
origins of replications is diﬀerent (on average, higher) in P. putida and
E. coli (Cook et al., 2018), which in turns impacts the catalytic capacity
of engineered P. putida in a strain- and regulatory system-dependent
fashion (Jahn et al., 2014; Lindmeyer et al., 2015). Besides plasmid-
based gene expression and manipulation, assembly and handling of
large DNA segments has been also incorporated to the toolbox recently
(Domröse et al., 2017).
The lack of well-established standards, which used to aﬄict not only
engineering eﬀorts using P. putida but essentially the entire ﬁeld of
synthetic biology, has only recently been tackled systematically. The
hallmark brought about by the Standard European Vector Architecture
(SEVA; a user-friendly, open-source toolbox platform in constant ex-
pansion) has helped to standardize the use of genetic parts that can be
applied for metabolic engineering of P. putida (Martínez-García et al.,
2014a; Silva-Rocha et al., 2013). Besides many of the gene expression
systems listed in Table 1, other functionalities have been formatted and
added to the SEVA collection, including Tn5- and Tn7-based transposon
vectors (Martínez-García et al., 2011, 2014a, 2014b, 2017; Nikel and de
Lorenzo, 2013a)—and the list of novel parts and devices therein con-
tinues to expand practically by the month. Needless to say, the incep-
tion of technologies based on clustered regularly interspaced short
palindromic repeats (CRISPR) and Cas9 (Jakočiūnas et al., 2017) re-
sulted in novel tools for targeted genome manipulations in P. putida,
including counter-selection strategies for targeted genome mutagenesis
(Aparicio et al., 2018; Mougiakos et al., 2017), gene down-regulation
(i.e., CRISPR interference) using catalytically deactivated Cas9 (Sun
et al., 2018; Tan et al., 2018), and precise plasmid curing (Lauritsen
et al., 2017). The impact of CRISPR/Cas-based gene editing techniques
is expected to reach genetically intractable microbial species (Shapiro
et al., 2018), and would be instrumental to harness the metabolic po-
tential of non-traditional Pseudomonas strains. For a recent update on
many of the currently available P. putida genetic toolbox, the reader is
referred to the recent review published by Martínez-García and de
Lorenzo (2017). Alas, given the relentless publication of more and more
genetic tools for P. putida and other non-E. coli microbial platforms,
chances are that their compilations become obsolete by the time they
are published.
Therefore, at the time of writing this article, the challenge is not so
much a dearth of synthetic biology tools. Instead, the task is about
pushing the boundaries of what P. putida can do towards biosynthesis of
compounds through importing and nurturing other microorganisms'
genes, and the «biologization» of otherwise purely chemical bonds and
structures. In other words, the frontier in the ﬁeld is moving from cis-
metabolism towards trans-metabolism. Some avenues to make progress
in this direction are discussed below.
3. From extant (cis) metabolism towards orthogonal (trans)
metabolism in the P. putida chassis
3.1. Design and construction of microbial cell factories afresh: Extant
biochemistries and synthetic metabolisms
The textbook deﬁnition of metabolism (from the Greek μεταβολή,
transformation or, more literally, change) could be summarized as «the
collection of life-sustaining chemical transformations within individual cells
of living organisms». The canonical deﬁnition implies an enumeration of
components of metabolism from a rather reductionist point of view;
something that does not come as a surprise since reductionism has
dominated biological research for over a century. Central carbon me-
tabolism provides energy and biomass precursors to the entire cellular
network, and its ﬁne regulation is essential to ensure optimal use of
substrates and proper allocation of resources to the metabolic pathways
that make up for the extant biochemistry of any cell. Overcoming this
ﬁne regulation has been the ultimate goal of traditional metabolic en-
gineering. From a broader perspective, a key challenge for biology in
the 21st century is to understand the structure and the dynamics of the
complex intercellular web of metabolic interactions that contribute to
the structure and functioning of the bacterial cell. This has led to the
realization that the relational logic of metabolic networks within a cell
is shared (to a large degree) by other complex systems, e.g., computer
chips and even modern society. This organizational universality in-
dicates that similar laws may govern most complex networks in Nature,
which allows the expertise from large and well-mapped non-biological
systems to be used in characterizing the intricate interwoven relation-
ships that govern metabolic functions. Systemic biology is the view of
live systems through the optics of such quantitative perspective, rela-
tional logic and analysis tools of bona ﬁde engineering being its core
tenets by merging systems and synthetic biology with metabolic ar-
chitectures and multi-scale organization of biological objects.
The process of moving from the study of individual components in
central carbon metabolism to re-purposing the whole biochemical
network implies that there should be a distinction between the extant
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(cis) biochemistry and the implanted (trans) metabolism. This opera-
tional deﬁnition indicates that, for some metabolic engineering pur-
poses, re-wiring the components of the cis-metabolism would result in
the formation of the target product(s), whereas the synthesis of new-to-
Nature compounds would require the design and incorporation of trans-
metabolic reactions into the bacterial chassis, e.g., involving novel
biochemical transformations. Accordingly, this description of cis- and
trans-metabolism conveys four categories of potential products, as
proposed by Lee et al. (2012) and as indicated in Fig. 4: (i) natural and
endogenous (metabolites that can be produced through native pathways
of P. putida), (ii) natural, exogenous (natural metabolites produced by
introducing an heterologous pathway that uses native precursors), (iii)
non-natural (and therefore, exogenous; metabolites not found in Nature
that can be produced by combining metabolic pathways, either native
or heterologous), and (iii) completely new-to-Nature (for which a com-
pletely synthetic pathway is needed, including novel enzymes and re-
actions). In the next sections, we discuss examples of these two types of
engineering operations in P. putida.
Table 1
Examples of gene expression systems and promoters designed using parts harnessed from Pseudomonas species or transplanted into P. putida for regulated gene
expression, along with some applications of these systems in metabolic engineering.
Expression system (inducer)a Source of regulatory
elements
Characterization and examples of uses in metabolic
engineeringb
Reference(s)
XylS/Pm (3-methylbenzoic acid) P. putida mt-2 Extensively characterized in E. coli and P. putida; p-
coumaric production in engineered P. putida strains;
heterologous expression of genes for fermentation under
low oxygen availability in P. putida
de Lorenzo et al. (1993a); Gawin et al. (2017);
Calero et al. (2016); Nikel and de Lorenzo
(2013b)
XylR/Pu (3-methylbenzyl alcohol) P. putida mt-2 Extensively characterized in E. coli and P. putida; expression
of phosphoglucomutase (celB) from Acetobacter xylinum in
recombinant E. coli and Xanthomonas campestris strains
Ramos et al. (1997); Marqués and Ramos
(1993); Blatny et al. (1997)
AlkS/PalkB (short-chain alkanes) P. putida GPo1 Characterized in E. coli and P. putida; production of (S)-
styrene oxide and heterologous proteins in recombinant E.
coli strains
Panke et al. (1999); Makart et al. (2007)
NahR/Psal (salicylic acid) P. putida NCIB 9816-4 Characterized in E. coli and P. putida; surface reporter of
catabolic promoter activity; gene expression cascade with
XylS variants
Cebolla et al., (1996, 2001); Becker et al.
(2010)
TodST/PtodX (4-chloroaniline) P. putida T-57 Characterized in E. coli Vangnai et al. (2012)
CymR/Pcym (4-isopropylbenzoic acid) P. putida F1 Characterized in E. coli Choi et al. (2010)
ClcR/PclcA (3- or 4-chlorocatechol) P. putida PRS2015 Characterized in P. putida Guan et al. (2000)
HpdR/PhpdH (3-hydroxypropionic
acid)
P. putida KT2440 Characterized in E. coli and Cupriavidus necator Hanko et al. (2017)
MmsR/PmmsA (3-hydroxypropionic
acid)
P. putida KT2440 Characterized in E. coli and Cupriavidus necator Hanko et al. (2017)
NagR/PnagA (salicylic acid) Comamonas testosteroni Production of 3-methylcatechol by P. putida Hüsken et al. (2001)
ChnR/PchnB (cyclohexanone) Acinetobacter johnsonii Characterized in E. coli; regulation of bioﬁlm formation in
engineered P. putida strains
Benedetti et al. (2016a), (2016b)
CprK/PDB3 (3-chloro-4-
hydroxyphenylacetic acid)
Desulﬁtobacterium
hafniense
Characterized in E. coli and P. putida Kemp et al. (2013)
MekR/PmekA (methyl-ethyl ketone) P. veronii Characterized in E. coli and P. putida; expression of cre for
recombineering in P. putida
Graf and Altenbuchner (2013); Luo et al.
(2016)
MtlR/PmtlE (mannitol) P. ﬂuorescens Characterized in E. coli and P. putida Hoﬀmann and Altenbuchner (2015)
AraC/ParaB (arabinose) E. coli Characterized in E. coli and P. putida; p-coumaric production
in engineered P. putida strains
Calero et al. (2016)
RhaRS/PrhaB (arabinose) E. coli Characterized in E. coli and P. putida; p-coumaric production
in engineered P. putida strains
Calero et al. (2016)
TetR/PtetA (anhydrotetracycline) E. coli Synthesis of myxochromide S (mchS biosynthetic gene
cluster from Stigmatella aurantiaca), epothilone (epo
biosynthetic gene cluster from Sorangium cellulosum), and
tubulysin (tub biosynthetic gene cluster from Cystobacter
sp.) in engineered P. putida strains
Fu et al. (2008); Chai et al. (2012)
LacIQ/Plac, Ptac, Ptrc (isopropyl β-D-1-
thiogalactopyranoside)
E. coli Extensively characterized in E. coli and P. putida; biological
containment of P. putida; production of long-chain
rhamnolipids and vanillin in engineered P. putida strains
de Lorenzo et al. (1993a,1993b); Pérez-Martín
and de Lorenzo (1996); Ronchel et al. (1995);
Wittgens et al. (2018); Graf and Altenbuchner
(2014)
PT5 Bacteriophage T5 Expression of 6×His-tagged proteins (pfrA siderophore
regulatory gene) in P. putida
Bertani et al. (1999)
PT7 Bacteriophage T7 Characterized in P. putida; containment of P. putida strains
by conditional expression of the streptavidin gene
Herrero et al. (1993); Szafranski et al. (1997)
PEM7 Synthetic, constitutive Characterized in P. putida; CRISPR-Cas9—based counter-
selection for genome manipulations in P. putida
Aparicio et al. (2018)
PoprL Synthetic, constitutive Characterized in P. putida; expression of a bacterial laccase
gene from Shigella dysenteriae and surface display in P.
putida
Llamas et al. (2003); Wang et al. (2012)
Pgro, Ptuf, Ptufs Synthetic, constitutive Tailor-made for calibrated gene expression in P. putida;
production of cis,cis-muconic acid
Kohlstedt et al. (2018)
PJE Synthetic, constitutive Tailor-made for calibrated gene expression in P. putida Elmore et al. (2017)
PSynP·BG Synthetic, constitutive Tailor-made for calibrated gene expression in P. putida Zobel et al. (2015)
a In some cases, more than one inducer can activate the expression system. Only the typical inducers are listed in the table (usually selected because they are the
cheapest and/or the most eﬀective).
b Only the ﬁrst example(s) of uses in practical applications are indicated, and also those studies that have adopted the corresponding expression system for
approaches beyond the customary characterization experiments in a surrogate host using ﬂuorescent proteins.
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3.2. Engineering of the cis-metabolism in action: Pseudomonas putida as a
host for eﬃcient degradation and production of aromatic compounds
The capacity of P. putida strains to degrade aromatic compounds
was recognized early on as a key signature of the species. The late
1980s and early 1990s witnessed the golden era of research in the
biodegradation of xenobiotic compounds, and the literature reﬂects the
numerous attempts that followed the pioneering work by Chakrabarty
while he was working at the Research and Development Center of
General Electric Co. At the time, four species of oil-metabolizing bac-
teria were known to exist, but when introduced into an oil spill, they
would compete with each other, thereby limiting the amount of crude
oil that they could degrade. Chakrabarty and co-workers described the
preparation of recombinant P. putida strains (which they called «multi-
plasmid hydrocarbon-degrading Pseudomonas») by means of plasmid-
assisted molecular breeding, i.e., propagation of novel catabolic cap-
abilities through directed bacterial conjugation and plasmid transfer
(Chakrabarty et al., 1975). The resulting strains were able to break
down two-thirds of all the hydrocarbons typically found in a crude oil
spill at rates one or two orders of magnitude faster than the previously
described individual strains of oil-eating bacteria, a set of results which
lead to the ﬁrst USA patent granted for a genetically modiﬁed organism
(Chakrabarty, 1981).
3.2.1. Biodegradation of aromatic compounds as a source of added-value
metabolites
The huge potential for biodegradation of aromatic compounds
written in the cis-metabolism of P. putida was exploited for transfor-
mations beyond the customary bioremediation approaches in the con-
text of which they were discovered (Dvořák et al., 2017). The practical
demonstration of this metabolic capability is represented by several
engineering strategies developed for the production of cis,cis-muconic
acid [(2E,4E) 2,4-hexanedioic acid]. This dicarboxylic acid is a relevant
platform chemical that is currently recognized for its high industrial
value (Xie et al., 2014)—cis,cis-muconic acid provides synthetic access
to terephthalic acid, 3-hexenedioic acid, 2-hexenedioic acid, 1,6-hex-
anediol, ε-caprolactam, and ε-caprolactone, all of which are important
building blocks of commercial plastics, resins, and polymers (e.g.,
Nylon-6,6 via adipic acid). The traditional chemical processes for its
production rely on non-renewable, oil-based feedstocks and high con-
centrations of heavy metal catalysts—and a mixture of the cis,cis- and
cis,trans-muconic acid isomers is obtained. The synthesis of cis,cis-mu-
conic acid in P. putida mt-2 takes place as an essential part of the upper
catabolic pathways dealing with the degradation of aromatic com-
pounds. All of these catabolic segments ultimately converge at the level
of catechol (1,2-dihydroxybenzene) as a central metabolic inter-
mediate, which then undergoes intradiol ring ortho-cleavage by the
action of catechol-1,2-dioxygenase to yield of cis,cis-muconic acid.
The inactivation of muconate cycloisomerase was one of the ﬁrst
attempts to enhance the production of cis,cis-muconic acid, given that
this enzyme would lactonize the target product and thereby reduce
yields. Such strategy enabled the production of cis,cis-muconic acid via
the catechol branch of the β-ketoadipate pathway directly from benzoic
acid and toluene (Chua and Hsieh, 1990). In addition, the expression of
phenol hydroxylating enzymes in P. putida KT2440 (i.e., the
dmpKLMNOP-encoded phenol monooxygenase from Pseudomonas sp.
strain CF600) enabled eﬃcient cis,cis-muconic acid synthesis from
phenol (Vardon et al., 2015). More recently, the entire protocatechuate
branch of the β-ketoadipate pathway was successfully connected to the
catechol node, thereby allowing for cis,cis-muconic acid formation from
an even greater number of precursors, including coniferyl alcohol, p-
coumarate, vanillate, ferulate, and protocatechuate itself (Johnson
et al., 2016). As a result, the upper pathways of P. putida for aromatic
compounds degradation were rendered a metabolic funnel to convert
heterogeneous mixtures of aromatics with catechol as a central inter-
mediate (Linger et al., 2014)—a circumstance that was adopted to re-
construct eﬃcient modular pathways for cis,cis-muconic acid synthesis
in engineered E. coli (Thompson et al., 2018).
3.2.2. From complex alternative feedstocks towards added-value
metabolites
Some of the most recent instances on the production of cis,cis-mu-
conic acid also oﬀer an example of the use of alternative substrates by
metabolically engineered P. putida, e.g., plant biomass containing
lignin. Extensively found in terrestrial plants, lignin is the second most
abundant biopolymer on Earth. With the advent of bioreﬁneries that
use plant biomass as a source of sugars, lignin has become a common
by-product with an enormous potential to be used as raw material in
the fuel and chemical industries. However, lignin remains the most
under-utilized lignocellulosic biopolymer (Rinaldi et al., 2016). The
catalytic potential of P. putida in taking part of this endeavor has not
passed unnoticed.
As indicated in the previous section, the catechol node plays a
central role in the production route leading to cis,cis-muconic acid
production since (i) all the upper segments of the catabolic pathways
for degradation of aromatic compounds ultimately yield catechol as the
central intermediate, (ii) catechol itself is frequently generated during
pre-treatment of lignin, and (iii) catechol is directly converted to the
target product by means of catechol-1,2-dioxygenase. However, one of
the main problems to overcome in production processes from lignin-
based feedstocks is the high toxicity of catechol. First, these raw ma-
terials can themselves contain signiﬁcant fractions of catechol. Second,
the conversion of crude mixtures of aromatic compounds requires the
engineering of heterologous catabolic pathways into the microbe, all of
which additionally contribute to catechol accumulation, potentially
leading to forced self-poisoning. These factors could explain why the
conversion of complex lignin liquors to cis,cis-muconic acid by en-
gineered P. putida strains has so far resulted in the accumulation of
signiﬁcant amounts of toxic upstream pathway intermediates (which
lower ﬁnal yields, and can altogether hamper the process) and in the
production of the target metabolite at only the milligram scale.
In an attempt to overcome this state of aﬀairs, Kohlstedt et al.
(2018) designed an entire genealogy of engineered P. putida KT2440
Fig. 4. The cis- and trans-metabolism realm, highlighting the role of synthetic
biology and metabolic engineering in bridging the gap with P. putida as the
functional chassis. Four categories of products are distinguished in either do-
main, depending on the metabolic pathways needed to synthesize them, and
typical examples are provided in each case. Note that entirely new-to-Nature
products are indicated in white lettering, as there are no cases reported for their
synthesis in P. putida.
P.I. Nikel, V. de Lorenzo Metabolic Engineering 50 (2018) 142–155
148
strains endowed with enhanced catechol tolerance and high conversion
eﬃciency, and having a wider substrate spectrum than other produc-
tion platforms. Diﬀerent metabolic conﬁgurations were tested in the
engineered strains, and cis,cis-muconic acid was produced from
benzoate, catechol, mixtures of catechol and phenol, and from a lignin
hydrolysate liquor (obtained via base catalysis and hydrothermal con-
version) in bioprocesses tested both at the laboratory- and at the pilot-
scale (50 L). When grown under fed-batch conditions using glucose as
the main carbon source, some of the engineered strains were able to
achieve a cis,cis-muconic acid titer of ca. 65 g L−1 and 13 g L−1 from
externally added catechol and from the lignin hydrolysate, respectively.
More importantly, these engineered cis,cis-muconic acid producers were
successfully applied to provide the ﬁrst case example of lignin-to-
Nylon-6,6 production via a cascaded biochemical and chemical in-
tegrated process. The bulk of the acid obtained in the process designed
by the authors was subsequently hydrogenated to adipic acid via a
chemical, Pd-assisted hydrogenation process, and the product was di-
rectly reacted with hexamethylenediamine to yield Nylon-6,6.
The dependence of these processes on sugars somehow compro-
mises the value of using lignin-derived substrates at the industrial level
that, as indicated above, are usually utilized as a co-feed. Novel meta-
bolic engineering strategies are being tested to overcome this problem,
and shift to lignin hydrolysates as the only carbon source fueling the
process. In a recent example of this sort, Sonoki et al. (2018) engineered
a P. putida KT2440-based strain to produce cis,cis-muconic acid from a
mixture of vanillic acid (i.e., a guaiacyl-lignin model) and 4-hydro-
xybenzoic acid (i.e., a p-hydroxyphenyl-lignin model) with a yield of ca.
20% (mol mol−1) without the need of glucose supplementation.
3.2.3. Production of aromatic compounds in P. putida
In the same way that P. putida is naturally equipped with the me-
tabolic machinery needed for the degradation of aromatic compounds,
this bacterium can be used as the functional chassis for the synthesis of
aromatic compounds—a situation that could lead to sustainable pro-
duction of some of them (used as building blocks for commodities),
since the industrial synthesis of aromatics currently relies almost ex-
clusively on petrochemical-based processes from benzene, toluene, and
xylenes (Lee and Wendisch, 2017). Several examples from the literature
indicate that P. putida has been engineered for the production of aro-
matic compounds that are often extremely toxic to be handled by other
microbial hosts, e.g., cinnamate, p-coumarate, p-hydroxybenzoate, and
phenol (Calero et al., 2018; Molina-Santiago et al., 2016). Although it is
not the purpose of this article to survey all these examples, a recent
addition to the literature of engineering the cis-metabolism of Pseudo-
monas for phenol production deserves attention considering its elegance
and simplicity (Wynands et al., 2018). Phenol is an aromatic com-
modity chemical with a multitude of applications in the chemical in-
dustry, and its biological production from tyrosine has been achieved
by introducing genes encoding tyrosine-phenol lyase from Pantoea ag-
glomerans or Pasteurella multocida in P. putida or E. coli strains (Wierckx
et al., 2005). However, the P. putida variants capable of producing
1.5 mM phenol from glucose with a yield< 7% C-mol C-mol−1 were
obtained by non-rational strain engineering techniques, i.e., random
mutagenesis followed by extensive high-throughput screening. Building
on the knowledge stemming from those early studies, P. taiwanesis (a
relative of P. putida) was forward- and reverse-engineered (22 mod-
iﬁcations in total) to ﬁnally yield a strain that bears no plasmids (all
relevant activities were integrated into the chromosome), and has no
auxotrophies (a problem that plagued the engineered P. putida strains
constructed thus far). The product titer and yield of phenol on glucose
reached by the best engineered candidate after 96 h of batchwise
shaken-ﬂask cultivation was ca. 3 mM and 16% C-mol C-mol−1, re-
spectively, which are the highest reported in the absence of any ad-
ditives (e.g., yeast extract) to the culture medium. Considering the high
performance of these engineered P. putida strains in producing phenol
from sugar substrates, it would be interesting to connect this metabolic
architecture with the catabolic segments discussed in the preceding
section leading to the synthesis of cis,cis-muconic acid to enable the
forward design of a high-yield cis,cis-muconic acid P. putida producer
from hexoses.
An entirely new chapter in the synthesis of aromatic compounds is
likely to arise from the recent discovery and identiﬁcation of enzymatic
activities for the synthesis of toluene (Beller et al., 2018). Microbial
sources of biogenic toluene were ﬁrst reported more than three decades
ago; however, the underlying biochemistry and speciﬁc enzymes that
catalyze toluene biosynthesis had never been elucidated until now.
Phenylacetate decarboxylation is catalyzed by the glycyl radical en-
zyme PhdB together with its cognate activating enzyme PhdA, a radical
S-adenosyl-L-methionine enzyme, and the activities were discovered in
two distinct anoxic microbial communities known to produce tolue-
ne—most likely by a non-cultivated microbial member (strain TolSyn)
of the Acidobacteria phylum. The unconventional process of enzyme
discovery from a complex microbial community (> 300,000 genes)
undertaken by the authors involved metagenomics- and metapro-
teomics-enabled biochemical analysis, as well as in vitro conﬁrmation of
activities using recombinant enzymes. Yet, the strictly anoxic nature of
these glycyl radical enzymes might hinder the design of a trans-meta-
bolism for aromatic compounds in P. putida KT2440, an obligate
aerobe—but there are emerging strategies at hand to overcome this
issue, as indicated in the next section.
3.3. Trans-metabolisms engineered in the P. putida chassis: Exploring the
untapped metabolic potential of environmental bacteria
The few examples presented in the preceding section are, in a nut-
shell, the practical demonstration of how ﬂexible the metabolism of P.
putida is, being able to host complex biochemistries that range from the
degradation of complex aromatic substrates down to simple, low-mo-
lecular-weight metabolites—and potentially back. This aspect is the
subject of the present section, in which we discuss some of the examples
available in the literature on the engineering of trans-metabolisms in P.
putida.
3.3.1. Engineering the oxygen-dependent lifestyle of P. putida
As diverse as the natural environmental niches inhabited by P. pu-
tida and other Pseudomonas are, they all share a physicochemical
characteristic: oxygen does not usually represent a nutritional limita-
tion. This feature is not surprising, as microbial activity in soil is known
to be spatially heterogeneous, and individual species often forming
spatial hotspots that diﬀerentially contribute to overall biogeochemical
processes. Mounting evidence had suggested that spatial organization
of bacterial species contributes to the persistence of anoxic hotspots in
soils—a hypothesis that has been recently conﬁrmed experimentally
with a soil-like system that includes both the obligate aerobe P. putida
and the facultative anaerobe P. veronii (Borer et al., 2018). The strictly
aerobic, highly oxidative cis-metabolism of P. putida, however, hampers
its broad application under micro-oxic and anoxic conditions, which in
turn excludes the utilization of oxygen-sensitive proteins and metabo-
lites. This situation also leads to complications when it comes to in-
dustrial-scale applications. On one hand, the operation of oxic biopro-
cesses it increases the capital cost, as scaling-up of these processes is
signiﬁcantly limited by the oxygen transfer rate and, due to this, both
the maximum and average scales of commercial oxic bioreactors are
much smaller in comparison with anoxic bioreactors (Ruiz et al., 2012).
On the other hand, oxygen-dependent bioproduction bring about some
degree of substrate loss in the form of CO2, while some anoxic processes
can achieve carbon yields close to theoretical yields. Against this
background, it is no surprise that engineering an anoxic P. putida chassis
has been the subject of intense research over the last few years, in-
cluding the quantitative study of the responses of P. putida to diﬀerent
agitation rates and oxygen availability in shaken-ﬂask cultures
(Rodríguez et al., 2018).
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Three types of engineering approaches can be distinguished, which
are based on (i) a trans-metabolism for mixed fermentation, (ii) a trans-
metabolism for nitrate-dependent respiration, and (iii) the adoption of
bioelectrochemical systems. In the ﬁrst type of engineering approach,
the genes encoding the acetate kinase from E. coli and the ethanol
biosynthesis pathway from Zymomonas mobiliswere introduced in strain
KT2440, which resulted in an extended survival in the absence of
oxygen (Nikel and de Lorenzo, 2013b). This anoxic-tolerant bacterial
chassis was further engineered by recruiting two haloalkane dehalo-
genases from P. pavonaceae, which conferred the ability of degrading
1,3-dichloprop-1-ene (a recalcitrant xenobiotic that neither wild-type P.
putida nor P. pavonaceae can degrade under anoxic conditions). In a
diﬀerent study, Steen et al. (2013) constructed two cosmids encoding
all the structural, maturation-related, and regulatory genes needed for
nitrate reductase and nitrite- and nitric oxide reductase from P. aeru-
ginosa in order to establish nitrate-dependent respiration in strain
KT2440. The resulting engineered strains eﬃciently reduced nitrate or
nitrite, which in turn sustained an extended anoxic lifespan. Finally, the
utilization of bioelectrochemical systems was exploited to develop
bioprocesses under conditions with limited oxygen supply. Schmitz
et al. (2015) engineered a P. putida KT2440 derivative able to synthe-
size phenazine redox-mediators by expressing the seven-gene cluster
phzA1-G1 together with phzM and phzS from P. aeruginosa PAO1. For-
mation of the redox-active pyocyanin allowed for partial redox balan-
cing with an electrode under micro-oxic conditions, and the biomass
yield on glucose of the engineered P. putida was doubled as compared
with the wild-type strain. Lai et al. (2016) used [Fe(CN)6]3− or [Co
(2,2′-bipyridine)3]3+ as the high midpoint potential redox mediator
when culturing P. putida F1 in the anodic compartment of a bioelec-
trochemical system ran under anoxic conditions in the presence of
glucose as the carbon source. Under these conditions, most of the glu-
cose was converted into 2-ketogluconate (with a yield of ca. 0.9mol
mol−1), and overexpression of the endogenous gluconate dehy-
drogenase in strain KT2440 boosted 2-ketogluconate formation under
similarly anoxic culture conditions by> 600% (Yu et al., 2018).
Despite all these valuable eﬀorts, no metabolically engineered P.
putida strain was able to actually grow in the absence of oxygen thus far,
which opens up the question of what are the factors missing in the
picture that need to be manipulated in order to accomplish the task. It is
likely that an authentic genome scale metabolic model-driven design of
an anaerobic trans-metabolism will help ﬁlling the knowledge gap that
currently limits the adoption of an oxygen-independent lifestyle by P.
putida—a situation that will soon be remediated by exploiting the in-
formation of the ﬁve genome-wide metabolic models currently avail-
able for strain KT2440 (Belda et al., 2016; Nogales et al., 2008;
Puchałka et al., 2008; Sohn et al., 2010; Yuan et al., 2017), including
the latest update by Nogales et al. (2017), in which the in silico meta-
bolic potential of P. putida has been fully evaluated in the most com-
prehensive metabolic reconstruction built to date. Meanwhile, and in
some cases with the support of such metabolic reconstructions, the al-
ready rich cis-metabolism of P. putida has been used to incorporate new
substrates for bioproduction, as disclosed in the section below.
3.3.2. Expansion of the range of carbon substrates
What makes a carbon source into a good substrate for P. putida?
Hintermayer and Weuster-Botz (2017) attempted to answer this ques-
tion by estimating the growth parameters of strain KT2440 in silico
using 57 individual carbon sources, and experimentally validated the
results in batch cultures carried out on six of them (i.e., acetate, gly-
cerol, citrate, succinate, malate, and methanol). Glycerol was the
carbon source that promoted the highest biomass yield on substrate
(0.61 C-mol C-mol−1) with a very good ﬁt between the in silico pre-
diction and the experimental validation. The use of glycerol has been
explored from a biochemical and genetic point of view in other studies
(Nikel et al., 2014a, 2015b), and it has been also used as a substrate to
design bioprocesses for the cost-eﬃcient production of
polyhydroxyalkanoates by P. putida (Beckers et al., 2016; Gomez et al.,
2012; Prieto et al., 2016). In fact, biopolymers constitute one of the
main products of the cis-metabolism of P. putida that has been exploited
for commercial production, and the reader is referred to the key lit-
erature in the domain for further information on polyester production
in engineered P. putida strains (Arias et al., 2013; Li et al., 2011; Liu
et al., 2011; Meng and Chen, 2018; Tripathi et al., 2012).
All these studies indicate that the nutritional landscape of typical P.
putida niches in Nature (including plant rhizosphere and polluted soils)
has pushed its metabolic specialization towards the use of organic acids,
amino acids, and aromatic substrates (Martins dos Santos et al., 2004).
Considering that glucose and xylose are the two most abundant
monosaccharide building blocks of the abundant polysaccharides cel-
lulose and hemicellulose in plant cell walls, both of them are attractive
sugars to be used as substrates in bioprocesses. Expansion of the cis-
metabolism of sugars in P. putida to assimilate industrially-relevant
hexose and pentose substrates is thus an important topic in the ﬁeld of
metabolic engineering since carbohydrates are not the preferred carbon
sources of environmental bacteria.
The carbohydrates on which P. putida KT2440 can grow are con-
ﬁned to some hexoses (glucose and fructose), but this strain is unable to
metabolize disaccharides or C5 sugars (Köhler et al., 2015), thus lim-
iting the number and nature of sugars that can be used in bioprocesses.
Dvořák and de Lorenzo (2018) expanded the cis-metabolism of a
genome-reduced variant of strain KT2440 to include disaccharides and
xylose as the carbon substrates by (i) plugging-in a β-glucosidase from
Thermobiﬁda fusca (i.e., the enzyme needed for intracellular hydrolysis
of cellobiose), (ii) and three separate activities from E. coli (i.e., a xylose
transporter, a xylose isomerase, and a xylulokinase), and (iii) blocking
the oxidative branch of sugar utilization by eliminating the endogenous
glucose dehydrogenase. When implemented together, these manipula-
tions enabled co-utilization and total utilization of both cellobiose and
xylose in minimal medium by the engineered strain.
Sucrose is another disaccharide alien to the extant catabolic po-
tential of P. putida. Being the main sugar component of molasses, thus
an interesting feedstock for bioproduction, Löwe et al. (2017a) en-
gineered a reduced-genome variant of strain KT2440 to acquire sucrose
permease and invertase activities by delivering the cscAB genes from E.
coli strain W into the chromosome via mini-Tn5 transposons. The re-
sulting P. putida variant not only grew on sucrose as the carbon source,
but it was also used as a platform strain for photoautotrophic poly-
hydroxyalkanoate production in a co-culture system along with cya-
nobacteria. In this setup, a mutant strain of Synechococcus elongatus
ﬁxes CO2 and converts it to sucrose, which is in turn used as the main
carbon source by the engineered P. putida strain to accumulate the in-
tracellular biopolymer with an overall productivity of ca. 24mg L−1
day−1 (Löwe et al., 2017b).
Other substrates beyond individual sugars are likewise relevant for
industrial production. Lignocellulose, for instance, can be decomposed
to cellulose (25–55%), hemicellulose (11–50%), and lignin (10–40%).
As most biomass conversion schemes for bioproduction employ a high-
temperature processing step, sometimes in the presence of an acid,
sugar dehydration products are inevitably formed (Ravindran and
Jaiswal, 2016). C5 and C6 sugars can be dehydrated into furfural and 5-
(hydroxymethyl)furfural, respectively, and these two compounds are
commonly formed during the thermochemical pretreatment, liquefac-
tion, or pyrolysis steps of lignocellulose processing. These aldehydes are
considered major inhibitors in microbial conversion processes, but
some microorganisms are known to convert these compounds to their
less toxic, dead-end alcohol counterparts, furfuryl alcohol and 5-(hy-
droxymethyl)furfuryl alcohol. P. putida KT2440 was engineered to
utilize both furfural and 5-(hydroxymethyl)furfural as sole carbon and
energy sources via genomic integration of the 12-kb hmf gene cluster,
encoding the eight enzymes previously characterized in Burkholderia
phytoﬁrmans that transform the two substrates in the common meta-
bolic intermediate 2-furoic acid (Guarnieri et al., 2017).
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4. Conclusions and future prospects: Towards a bona ﬁde trans-
metabolism in P. putida
The examples discussed in the sections above illustrate the potential
of P. putida in nesting a suite of biochemical pathways from very diverse
sources, and in some of these cases, the adoption of harsh reactions
demonstrated that only a robust chassis can be used to host them. In this
concluding section, we summarize the challenges ahead for the design
and implementation of entirely new trans-metabolisms in the P. putida
chassis—in particular, considering the strategies that will help the ex-
ploration of the interphase between the extant, core biochemistry and
all the reactions within the realm of the allowed metabolism (Fig. 5).
4.1. Assimilation of non-biological chemical elements
Most of the examples of metabolic engineering of bioproducts (and
all of the cases that made their way up to commercialization) are pri-
marily limited to molecules resulting from the combination of only six
common elements (i.e., carbon, hydrogen, oxygen, nitrogen, phos-
phorus, and sulfur). Expanding the chemical palate of microbial cell
factories is one of the most sought after objectives in the ﬁeld nowadays
(Reed and Alper, 2018). Enabling novel elemental chemistries within
cellular systems will be a major contribution of the systemics biology
era to expand the scope of renewable chemistries performed by mi-
croorganisms. Among the many uncommon chemical elements that can
ﬁnd their way into biological molecules, halogens are particularly at-
tractive as halogenated organic compounds play a major role in the
pharmaceutical, diagnostic, agricultural, and materials industries
(O'Hagan and Deng, 2015; Walker and Chang, 2014). While halo-
genation of organic compounds using synthetic chemistry is well-es-
tablished (O'Hagan, 2008), these procedures are often characterized by
highly toxic chemicals and low yields due to diﬃculty of separation and
puriﬁcation of enantiomeric substances. Fluorine, the 13th most
abundant chemical element on the Earth crust and the most electro-
negative atom in the periodic table, is such an instance. Due to its
unique chemical properties, ﬂuorine has been incorporated into drugs
to modify their properties: since the C–F bond is much more hydro-
phobic than the C–H bond, ﬂuorination aﬀects basicity and enhances
lipophilicity, helping cell membrane penetration and increasing bioa-
vailability. Nature, however, has hardly evolved biochemical reactions
involving ﬂuorine (O'Hagan et al., 2002). This state of aﬀairs contrasts
with the contemporary demand for pharmaceutically-relevant ﬂuori-
nated biomolecules and building blocks as ca. 25% of the drugs cur-
rently licensed contain some type of ﬂuorinated structures. One of the
main problems in designing a trans-metabolism for targeted ﬂuorina-
tion may ﬁnd a practical solution in P. putida: low-molecular-weight
organoﬂuorines are known to be very toxic to most cells—but the in-
sight gained from the remarkable chemical feats of P. putida can be used
to engineer heftier production platforms that can incorporate the ex-
treme biochemistry of ﬂuorine and other halogens. Besides, Pseudo-
monads species are among the best platforms known for dehalogena-
tion of organohalides (Dvořák et al., 2017; van Pée and Unversucht,
2003), which indicates that the native biochemistry of these species can
handle halogenated structures.
Another two elements that seldom form part of the native bio-
chemistry of living cells could soon ﬁnd an adequate biochemical en-
vironment in P. putida for the development of trans-metabolisms aimed
at bioproduction. Directed evolution of proteins has paved the way for
bringing boron and silicon into the biochemical agenda of bacteria
(Arnold, 2018). Representing a 30% of the total mass of the Earth crust,
silicon is chemically very similar to carbon, and it has been hinted that
microorganisms and biocatalysts may have a greater capacity for novel
silicon-heteroatom bonds than what has been discovered previously.
The ﬁrst instance of an enzyme directly catalyzing the formation of a
C–Si bond was demonstrated by using an engineered variant of a cy-
tochrome c from the extremophile Rhodothermus marinus (Kan et al.,
2016). The catalytic scope of this cytochrome was further expanded to
include boron, providing access to 16 novel optically-active organo-
boranes (Kan et al., 2017). These smart strategies for bio-sylylation and
bio-borylation open up a novel chapter in trans-metabolism that will be
surely expanded in the coming years.
4.2. Utilization of alternative carbon substrates
The use of lignocellulosic biomass as an alternative feedstock in
bioprocesses is sometimes criticized as it can potentially undermine
food security, and also because it is constrained by limited availability
and ineﬃcient processing. The replacement of fossil and agricultural
feed-stocks with sustainable alternatives for the production of chemi-
cals and fuels is thus a societal and environmental necessity. A pro-
mising bioproduction strategy could be the use of reduced inorganic or
one-carbon (C1) electron donors to provide reducing power and energy
to drive CO2 ﬁxation, as shown in vitro (Erb and Zarzycki, 2016), e.g.,
CO, methane, methanol, and formic acid (Claassens et al., 2018). Such
C1 compounds could be sustainably obtained from waste streams or
readily regenerated by the use of unlimited resources (e.g., as light,
water, and CO2). Also, engineering synthesis of sugars in vivo, out of
CO2 has been achieved in E. coli (Antonovsky et al., 2016). If complex
enzymatic systems for both electron transfer and carbon capture were
expressed in heterotrophic bacteria, P. putida could constitute an in-
teresting alternative to develop a trans-metabolic route for CO2 ﬁxation
(Schwander et al., 2016). Production of, e.g., biofuels would then be
eased by the innate high solvent tolerance of this bacterium (Blank
et al., 2008; Ramos et al., 2015; Smith, 1990).
4.3. Novel biochemistries for structurally complex metabolites
Natural products are widely used as pharmaceuticals and in agro-
chemistry. Many products traditionally produced using P. putida as a
microbial cell factory by chemical and biotechnological companies
(e.g., Pﬁzer, Lonza, DSM, DuPont, and BASF) have been mostly focused
on this family of compounds (Poblete-Castro et al., 2012). The main
interest on these chemical structures currently relies on their extra-
ordinary value as precursors for the pharmaceutical industry, especially
when it comes to the synthesis of chiral molecules that are particularly
diﬃcult to synthesize using traditional chemical methods (Liu et al.,
2017). Complex natural products are often synthesized by
Fig. 5. Towards adoption of novel trans-metabolisms in P. putida. In order to
push the extant biochemistry of the cells into its very boundaries and explore
the plethora of potential new-to-Nature products lying there, synthetic path-
ways (consisting, in some cases, of a purposeful assembly of enzymes speciﬁ-
cally evolved for the task) need to be plugged-in in the chassis. Note that all the
possible biochemical reactions brought about by a synthetic metabolism are
constrained by thermodynamics. The typical chemical elements that form part
of the cis-metabolism, as well as those that would be desirable to bring as part of
the core biochemistry of the cell for practical applications, are indicated in
either side of the diagram.
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multifunctional mega-synthetases, e.g., multi-domain polyketide syn-
thases (Barajas et al., 2017), the engineering and heterologous ex-
pression of which oﬀer huge promise for bioproduction, especially if the
natural hosts are genetically intractable, slow growing or unculturable,
or even unknown. The assembly of polyketide synthases seems to be a
particularly attractive possibility in this respect to access products
completely alien to the biochemistry of P. putida, especially considering
that these modular enzymes can be assembled in diﬀerent conﬁgura-
tions to further expand their catalytic repertoire. Apart from the me-
tabolites brought about by these natural pathways, the structural
complexity of novel carbon compounds continues to expand by enzyme
engineering and evolution (Erb et al., 2017) to include small carbo-
cycles, e.g., cyclopropane and bicyclobutanes (Chen et al., 2018). In all
these cases, a central aspect (unfortunately seldom explored in meta-
bolic engineering designs) when introducing metabolites completely
alien to the extant biochemistry is the importance of establishing eﬃ-
cient metabolite repair systems (Sun et al., 2017).
4.4. Dynamic metabolic engineering
Synthetic biology has provided a wealth of gene circuits repurposed
as tools for engineering cellular behavior to be dynamically controlled
via transplantation of feedback loops, diverting feedback loop outputs,
or coupling sensory inputs with control devices. However, the potential
of such circuits has not been fully exploited for metabolic
engineering—let alone in P. putida. As recently indicated by Chen and
Liu (2018), gene circuits can be divided into three categories based on
signal sources: (i) environmental circuits that sense environmental sig-
nals (e.g., light, temperature, and population density), (ii) extracellular
circuits that sense extracellular chemical stimuli, and (iii) intracellular
circuits that sense the accumulation of intracellular chemicals (e.g.,
endogenous and exogenous metabolites). Dynamically-regulated sys-
tems could oﬀer higher catalytic outputs than the customary systems
used for metabolic engineering (Tan and Prather, 2017). The regulatory
network that rules biodegradation pathways in P. putida oﬀer a unique
starting point to design such circuits to dynamically control synthetic
metabolisms (e.g., as indicated in Fig. 3B). The adoption of particular
interpretation frameworks for the design of these circuits would be a
necessary step towards their implementation, and the formalism of
logic gates from electronics (Moon et al., 2012) would be one of the
tools to facilitate further engineering of trans-metabolisms in P. putida.
4.5. From the test tube to the bioreactor
Despite the value of P. putida as a metabolic engineering chassis
argued above, this platform is not alien to the paradox that permeates
virtually all microorganisms of industrial interest: the frequent gap
between creating a new metabolic property in the laboratory (as dis-
cussed above) and developing a large-scale process to ﬁll the breach
between design and actual production (Danchin, 2012). One thing is to
engineer a quality of interest in the test tube or in a small bioreactor
and a quite diﬀerent one is to implement a complete ﬂowchart for
manufacturing bulk amounts of chemicals able to actually compete with
oil-based counterparts (Sanford et al., 2016). Conspicuous challenges to
be addressed include the frequent lack of genomic stability of whole-
cell catalysts when bearing complex DNA constructs, the reliance on
(large volumes of) sterile liquid media for bacterial growth, and the
diﬃculty of downstream processing for recovering the products of in-
terest. These circumstances make the actual industrial use of en-
gineered P. putida strains to be mostly limited to high-added value
molecules produced in small-to-medium volume fermentations. Devel-
oping strategies for scaling-up the corresponding operations and
making them economically viable are thus as important for the bio-
technological outcome of this species as the deep genetic engineering
attempts discussed in the sections above. In particular, eﬃcient ap-
proaches for high-cell-density cultivation of engineered P. putida are
needed to reach productivities compatible with commercialization of
target products (Davis et al., 2015; Diniz et al., 2004; Lee et al., 2000;
Sun et al., 2006). The regulatory circuits that are known to aﬀect cell
density-dependent physiological traits (e.g., quorum sensing) should be
tackled accordingly. Increasing long-term stability of the whole-cell
catalysts, achieving high catalytic performance under low-water con-
ditions, and making downstream processing easy are challenges that
raise by themselves major scientiﬁc questions. Curbing evolvability
(Umenhoﬀer et al., 2010), phenotypic heterogeneity (Nikel and de
Lorenzo, 2018), managing water-limitation and saline stress (Yin et al.,
2015), and engineering eﬃcient secretion systems (Zhou et al., 2018)
will help making the diﬀerence between mere academic curiosity and
full-ﬂedged (and economically proﬁtable) industrial applications. Even
when some eﬀorts have been made in this direction, they are still
clearly insuﬃcient to bring about the much pursued shift between an
oil-based economy into a biosustainable chemical industry (de Lorenzo
et al., 2018; Timmis et al., 2017). While these bottlenecks will hopefully
be tackled in the near future, we strongly advocate the worth of P.
putida for framing the ﬁeld of metabolic engineering in the wider
context of the ongoing 4th Industrial Revolution (Schwab, 2016).
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